37 results on '"Chiara Arrigoni"'
Search Results
2. A personalized osteoarthritic joint-on-a-chip as a screening platform for biological treatments
- Author
-
Dalila Petta, Daniele D'Arrigo, Shima Salehi, Giuseppe Talò, Lorenzo Bonetti, Marco Vanoni, Luca Deabate, Luigi De Nardo, Gabriele Dubini, Christian Candrian, Matteo Moretti, Silvia Lopa, and Chiara Arrigoni
- Subjects
Joint-on-a-chip ,Osteoarthritis ,Microfluidics ,Chondrogenic matrix ,Orthobiologics ,Cartilage ,Medicine (General) ,R5-920 ,Biology (General) ,QH301-705.5 - Abstract
Osteoarthritis (OA) is a highly disabling pathology, characterized by synovial inflammation and cartilage degeneration. Orthobiologics have shown promising results in OA treatment thanks to their ability to influence articular cells and modulate the inflammatory OA environment. Considering their complex mechanism of action, the development of reliable and relevant joint models appears as crucial to select the best orthobiologics for each patient.The aim of this study was to establish a microfluidic OA model to test therapies in a personalized human setting. The joint-on-a-chip model included cartilage and synovial compartments, containing hydrogel-embedded chondrocytes and synovial fibroblasts, separated by a channel for synovial fluid. For the cartilage compartment, a Hyaluronic Acid-based matrix was selected to preserve chondrocyte phenotype. Adding OA synovial fluid induced the production of inflammatory cytokines and degradative enzymes, generating an OA microenvironment. Personalized models were generated using patient-matched cells and synovial fluid to test the efficacy of mesenchymal stem cells on OA signatures. The patient-specific models allowed monitoring changes induced by cell injection, highlighting different individual responses to the treatment. Altogether, these results support the use of this joint-on-a-chip model as a prognostic tool to screen the patient-specific efficacy of orthobiologics.
- Published
- 2024
- Full Text
- View/download PDF
3. Complex or not too complex? One size does not fit all in next generation microphysiological systems
- Author
-
Simone Bersini, Chiara Arrigoni, Giuseppe Talò, Christian Candrian, and Matteo Moretti
- Subjects
Bioengineering ,Biomaterials ,Science - Abstract
Summary: In the attempt to overcome the increasingly recognized shortcomings of existing in vitro and in vivo models, researchers have started to implement alternative models, including microphysiological systems. First examples were represented by 2.5D systems, such as microfluidic channels covered by cell monolayers as blood vessel replicates. In recent years, increasingly complex microphysiological systems have been developed, up to multi-organ on chip systems, connecting different 3D tissues in the same device. However, such an increase in model complexity raises several questions about their exploitation and implementation into industrial and clinical applications, ranging from how to improve their reproducibility, robustness, and reliability to how to meaningfully and efficiently analyze the huge amount of heterogeneous datasets emerging from these devices. Considering the multitude of envisaged applications for microphysiological systems, it appears now necessary to tailor their complexity on the intended purpose, being academic or industrial, and possibly combine results deriving from differently complex stages to increase their predictive power.
- Published
- 2024
- Full Text
- View/download PDF
4. Differential angiogenesis of bone and muscle endothelium in aging and inflammatory processes
- Author
-
Chiara Arrigoni, Paola Ostano, Simone Bersini, Martina Crippa, Maria Vittoria Colombo, Mara Gilardi, Luigi Zagra, Maurizia Mello-Grand, Ilaria Gregnanin, Carmen Ghilardi, Maria Rosa Bani, Christian Candrian, Giovanna Chiorino, and Matteo Moretti
- Subjects
Biology (General) ,QH301-705.5 - Abstract
Angiogenic analysis and transcriptomics on bone and skeletal muscle endothelial cells from osteoarthritis patients reveal different inflammatory conditions have a different impact on these cell populations.
- Published
- 2023
- Full Text
- View/download PDF
5. Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma
- Author
-
Florencia Cidre-Aranaz, Jing Li, Tilman L. B. Hölting, Martin F. Orth, Roland Imle, Stefanie Kutschmann, Giulia Ammirati, Katharina Ceranski, Martha Julia Carreño-Gonzalez, Merve Kasan, Aruna Marchetto, Cornelius M. Funk, Felix Bestvater, Simone Bersini, Chiara Arrigoni, Matteo Moretti, Uwe Thiel, Daniel Baumhoer, Felix Sahm, Stefan M. Pfister, Wolfgang Hartmann, Uta Dirksen, Laura Romero-Pérez, Ana Banito, Shunya Ohmura, Julian Musa, Thomas Kirchner, Maximilian M. L. Knott, and Thomas G. P. Grünewald
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2022
- Full Text
- View/download PDF
6. A microfluidic model of human vascularized breast cancer metastasis to bone for the study of neutrophil-cancer cell interactions
- Author
-
Martina Crippa, Giuseppe Talò, Anaïs Lamouline, Sara Bolis, Chiara Arrigoni, Simone Bersini, and Matteo Moretti
- Subjects
Biofabrication ,Microfluidics ,Bone metastasis ,Neutrophil ,Microvascular network ,Medicine (General) ,R5-920 ,Biology (General) ,QH301-705.5 - Abstract
The organ-specific metastatization of breast cancer to bone is driven by specific interactions between the host microenvironment and cancer cells (CCs). However, it is still unclear the role that circulating immune cells, including neutrophils, play during bone colonization (i.e. pro-tumoral vs. anti-tumoral). Here, we aimed at analyzing the migratory behavior of neutrophils when exposed to breast CCs colonizing the bone and their contribution to the growth of breast cancer micrometastases. Based on our previous bone metastasis models, we designed a microfluidic system that allows to independently introduce human vascularized breast cancer metastatic seeds within a bone-mimicking microenvironment containing osteo-differentiated mesenchymal stromal cells and endothelial cells (ECs). ECs self-assembled into microvascular networks and connected the bone-mimicking microenvironment with the metastatic seed. Compared to controls without CCs, metastatic seeds compromised the architecture of microvascular networks resulting in a lower number of junctions (5.7 ± 1.2 vs. 18.8 ± 4.5, p = 0.025) and shorter network length (10.5 ± 1.0 vs. 13.4 ± 0.8 [mm], p = 0.042). Further, vascular permeability was significantly higher with CCs (2.60 × 10−8 ± 3.59 × 10−8 vs. 0.53 × 10−8 ± 0.44 × 10−8 [cm/s], p = 0.05). Following metastatic seed maturation, neutrophils were injected into microvascular networks resulting in a higher extravasation rate when CCs were present (27.9 ± 13.7 vs. 14.7 ± 12.4 [%], p = 0.01). Strikingly, the percentage of dying CCs increased in presence of neutrophils, as confirmed by confocal imaging and flow cytometry on isolated cells from the metastatic seeds. The biofabricated metastatic niche represents a powerful tool to analyze the mechanisms of interaction between circulating immune cells and organ-specific micrometastases and to test novel drug combinations targeting the metastatic microenvironment.
- Published
- 2022
- Full Text
- View/download PDF
7. Chronic Monteggia in pediatric population: A narrative literature review
- Author
-
Chiara Arrigoni and Nunzio Catena
- Subjects
missed Monteggia ,chronic Monteggia ,child ,Bado’s classification ,Letts’s classification ,Pediatrics ,RJ1-570 ,Surgery ,RD1-811 - Abstract
Monteggia lesion is a traumatic condition that affects the forearm and is characterized by the association of an ulna fracture with a dislocation of the radius capitellar and proximal radius ulnar joints in the majority of cases. Although several authors have contributed to the understanding of this pathology over the years, it remains a challenge for orthopedists, and if not recognized and treated properly, it can have serious consequences. In these cases, a chronic injury develops, which is even more difficult to manage in terms of timing and treatment options. A narrative review of the literature on missed elbow injuries in children was conducted, and chronic Monteggia was the most frequently encountered injury. The analysis of the articles attempts to clarify some points and draw general conclusions on which to reflect.
- Published
- 2022
- Full Text
- View/download PDF
8. Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
- Author
-
Aruna Marchetto, Shunya Ohmura, Martin F. Orth, Maximilian M. L. Knott, Maria V. Colombo, Chiara Arrigoni, Victor Bardinet, David Saucier, Fabienne S. Wehweck, Jing Li, Stefanie Stein, Julia S. Gerke, Michaela C. Baldauf, Julian Musa, Marlene Dallmayer, Laura Romero-Pérez, Tilman L. B. Hölting, James F. Amatruda, Andrea Cossarizza, Anton G. Henssen, Thomas Kirchner, Matteo Moretti, Florencia Cidre-Aranaz, Giuseppina Sannino, and Thomas G. P. Grünewald
- Subjects
Science - Abstract
Ewing sarcoma is characterized by the fusion of EWSR1 and FLI1. Here, the authors show that EWSR1-FLI1 increases the activity of the developmental transcription factor SOX6, which promotes tumor growth but also increases sensitivity to oxidative stress.
- Published
- 2020
- Full Text
- View/download PDF
9. Advanced Microfluidic Models of Cancer and Immune Cell Extravasation: A Systematic Review of the Literature
- Author
-
Carlotta Mondadori, Martina Crippa, Matteo Moretti, Christian Candrian, Silvia Lopa, and Chiara Arrigoni
- Subjects
extravasation ,microfluidic ,cancer cells ,immune cells ,in vitro models ,Biotechnology ,TP248.13-248.65 - Abstract
Extravasation is a multi-step process implicated in many physiological and pathological events. This process is essential to get leukocytes to the site of injury or infection but is also one of the main steps in the metastatic cascade in which cancer cells leave the primary tumor and migrate to target sites through the vascular route. In this perspective, extravasation is a double-edged sword. This systematic review analyzes microfluidic 3D models that have been designed to investigate the extravasation of cancer and immune cells. The purpose of this systematic review is to provide an exhaustive summary of the advanced microfluidic 3D models that have been designed to study the extravasation of cancer and immune cells, offering a perspective on the current state-of-the-art. To this end, we set the literature search cross-examining PUBMED and EMBASE databases up to January 2020 and further included non-indexed references reported in relevant reviews. The inclusion criteria were defined in agreement between all the investigators, aimed at identifying studies which investigate the extravasation process of cancer cells and/or leukocytes in microfluidic platforms. Twenty seven studies among 174 examined each step of the extravasation process exploiting 3D microfluidic devices and hence were included in our review. The analysis of the results obtained with the use of microfluidic models allowed highlighting shared features and differences in the extravasation of immune and cancer cells, in view of the setup of a common framework, that could be beneficial for the development of therapeutic approaches fostering or hindering the extravasation process.
- Published
- 2020
- Full Text
- View/download PDF
10. Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
- Author
-
Aruna Marchetto, Shunya Ohmura, Martin F. Orth, Maximilian M. L. Knott, Maria V. Colombo, Chiara Arrigoni, Victor Bardinet, David Saucier, Fabienne S. Wehweck, Jing Li, Stefanie Stein, Julia S. Gerke, Michaela C. Baldauf, Julian Musa, Marlene Dallmayer, Laura Romero-Pérez, Tilman L. B. Hölting, James F. Amatruda, Andrea Cossarizza, Anton G. Henssen, Thomas Kirchner, Matteo Moretti, Florencia Cidre-Aranaz, Giuseppina Sannino, and Thomas G. P. Grünewald
- Subjects
Science - Abstract
A Correction to this paper has been published: https://doi.org/10.1038/s41467-020-20017-2
- Published
- 2020
- Full Text
- View/download PDF
11. Umbilical Cord MSCs and Their Secretome in the Therapy of Arthritic Diseases: A Research and Industrial Perspective
- Author
-
Chiara Arrigoni, Daniele D’Arrigo, Valeria Rossella, Christian Candrian, Veronica Albertini, and Matteo Moretti
- Subjects
umbilical cord MSC ,secretome ,osteoarthritis ,extracellular vesicles ,cell therapies ,Cytology ,QH573-671 - Abstract
The prevalence of arthritic diseases is increasing in developed countries, but effective treatments are currently lacking. The injection of mesenchymal stem cells (MSCs) represents a promising approach to counteract the degenerative and inflammatory environment characterizing those pathologies, such as osteoarthritis (OA). However, the majority of clinical approaches based on MSCs are used within an autologous paradigm, with important limitations. For this reason, allogeneic MSCs isolated from cord blood (cbMSCs) and Wharton’s jelly (wjMSCs) gained increasing interest, demonstrating promising results in this field. Moreover, recent evidences shows that MSCs beneficial effects can be related to their secretome rather than to the presence of cells themselves. Among the trophic factors secreted by MSCs, extracellular vesicles (EVs) are emerging as a promising candidate for the treatment of arthritic joints. In the present review, the application of umbilical cord MSCs and their secretome as innovative therapeutic approaches in the treatment of arthritic joints will be examined. With the prospective of routine clinical applications, umbilical cord MSCs and EVs will be discussed also within an industrial and regulatory perspective.
- Published
- 2020
- Full Text
- View/download PDF
12. Adult Hip Flexion Contracture due to Neurological Disease: A New Treatment Protocol—Surgical Treatment of Neurological Hip Flexion Contracture
- Author
-
Alberto Nicodemo, Chiara Arrigoni, Andrea Bersano, and Alessandro Massè
- Subjects
Medicine - Abstract
Congenital, traumatic, or extrinsic causes can lead people to paraplegia; some of these are potentially; reversible and others are not. Paraplegia can couse hip flexion contracture and, consequently, pressure sores, scoliosis, and hyperlordosis; lumbar and groin pain are strictly correlated. Scientific literature contains many studies about children hip flexion related to neurological diseases, mainly caused by cerebral palsy; only few papers focus on this complication in adults. In this study we report our experience on surgical treatment of adult hip flexion contracture due to neurological diseases; we have tried to outline an algorithm to choose the best treatment avoiding useless or too aggressive therapies. We present 5 cases of adult hips flexion due to neurological conditions treated following our algorithm. At 1-year-follow-up all patients had a good clinical outcome in terms of hip range of motion, pain and recovery of walking if possible. In conclusion we think that this algorithm could be a good guideline to treat these complex cases even if we need to treat more patients to confirm this theory. We believe also that postoperation physiotherapy it is useful in hip motility preservation, improvement of muscular function, and walking ability recovery when possible.
- Published
- 2014
- Full Text
- View/download PDF
13. Vascular Tissue Engineering
- Author
-
Chiara Arrigoni, Davide Camozzi, and Andrea Remuzzi
- Subjects
Medicine - Abstract
Reconstructive surgery using autologous vessels is the conventional approach for substitution of diseased vessels or for generation of bypass to improve blood supply downstream of stenosed vessels. In some circumstances the use of autologous material is not possible due to concomitant diseases or previous use, and artificial grafts must be used. Unfortunately, these grafts cannot substitute small-caliber arterial vessels because of thrombotic complications. The objective of tissue engineering at the vascular level is then to generate biological substitutes of arterial conduits with functional characteristics of native vessels, combining cellular components with biodegradable scaffolds. These research projects started in several laboratories, in the late 1990s, and have expanded in different directions using a number of experimental approaches. The objective of this review is to give an overview of the results so far obtained in this area of research, and to discuss the problems related to these investigations, at the experimental and clinical level. The article provides an overview of different biodegradable scaffolds used, experimental techniques for vessels maturation in vitro under mechanical stimulation, and of differentiated as well as precursors of vascular cells, which opens new opportunities for further development of this form of cell transplantation. Finally, the current available results in clinical research will be discussed.
- Published
- 2006
- Full Text
- View/download PDF
14. Organs-on-a-chip as model systems for multifactorial musculoskeletal diseases
- Author
-
Silvia Lopa, Christian Candrian, Matteo Moretti, and Chiara Arrigoni
- Subjects
0106 biological sciences ,Mechanical overload ,0303 health sciences ,Basic science ,business.industry ,Drug Evaluation, Preclinical ,Biomedical Engineering ,Bioengineering ,Models, Biological ,01 natural sciences ,Organ-on-a-chip ,03 medical and health sciences ,Lab-On-A-Chip Devices ,010608 biotechnology ,Bone cell ,Inflammatory molecules ,Humans ,Medicine ,Disease characteristics ,Musculoskeletal Diseases ,business ,Neuroscience ,030304 developmental biology ,Biotechnology - Abstract
Multifactorial diseases affecting musculoskeletal tissues are characterized by the interactions between multiple tissues, such as muscle and nerves in neuromuscular diseases, or multiple cellular components in a tissue, as in the case of bone tumors, interacting with bone cells. For these diseases also the influence of different biophysical and biochemical stimuli, such as mechanical overload and inflammatory molecules in osteoarthritis, play a key role. To investigate these complex phenomena, organ-on-a-chip systems have been developed, taking into account specific disease characteristics such as being directly derived from patients, the presence of specifically mutated cells, or a combination of relevant biophysical and/or biochemical stimuli. Depending on the envisaged application, different issues remain to be addressed. In particular, improving automation and output sensors are key for drug screening applications, while refining model microarchitecture to enhance physiological fidelity is needed for more basic science studies.
- Published
- 2020
- Full Text
- View/download PDF
15. Systems biology analysis identifies TCF7L1 as a key regulator of metastasis in Ewing sarcoma
- Author
-
Martin F. Orth, Florencia Cidre-Aranaz, Laura Romero-Pérez, G. Ammirati, Felix Bestvater, T. G. P. Gruenewald, S. Bersini, Max M. L. Knott, Chiara Arrigoni, Julian Musa, Martha J. Carreño-Gonzalez, Roland Imle, Matteo Moretti, S. Kutschmann, Shunya Ohmura, Aruna Marchetto, Jing Li, Cornelius M. Funk, Thomas Kirchner, Ana Banito, Katharina Ceranski, Merve Kasan, and Tilman L. B. Hoelting
- Subjects
Oncogene ,TCF3 ,medicine ,Regulator ,Cancer research ,Cancer ,Sarcoma ,Biology ,Carcinogenesis ,medicine.disease_cause ,medicine.disease ,Transcription factor ,Metastasis - Abstract
Identification of cancer stemness genes is crucial to understanding the underlying biology of therapy resistance, relapse, and metastasis. Ewing sarcoma (EwS) is the second most common bone tumor in children and adolescents. It is a highly aggressive cancer associated with a dismal survival rate (EWSR1-ETS). Thus, EwS constitutes an ideal model to study how perturbation of a transcriptional network by a dominant oncogene can mediate metastasis, even though canonical metastasis-associated genes are not mutated.Here, through the implementation of an integrative systems biology approach, we identified transcription factor 7 like 1 (TCF7L1, alias TCF3) as a prognostically-relevant and EWSR1-ETS suppressed determinant of metastasis in EwS. We demonstrated that conditional TCF7L1 re-expression significantly reduces EwS single-cell migration, invasion and anchorage-independent growth in 3D assays in vitro, and tumorigenesis in vivo mediated by its DNA binding domain. In primary EwS tumors as well as in functional orthotopic in vivo models, low TCF7L1 expression was associated with pro-metastatic gene signatures and a much higher migratory and metastatic capacity of EwS cells, which correlated with poor outcome of EwS patients.Collectively, our findings establish TCF7L1 as a major regulator of metastasis in EwS, which may be utilized as a prognostic biomarker and open inroads to future therapeutic intervention.
- Published
- 2021
- Full Text
- View/download PDF
16. Improving cell seeding efficiency through modification of fiber geometry in 3D printed scaffolds
- Author
-
Christian Candrian, Elena Bianchi, Valerio Luca Mainardi, Giuseppe Talò, Gabriele Dubini, Chiara Arrigoni, Marco Delcogliano, Marinella Levi, and Matteo Moretti
- Subjects
Scaffold ,Materials science ,0206 medical engineering ,Biomedical Engineering ,Bioreactor ,3D printing ,Bioengineering ,02 engineering and technology ,Biochemistry ,Biomaterials ,Bioreactors ,Tissue engineering ,Porous scaffold ,Phase (matter) ,Shear stress ,Fiber ,Tissue Engineering ,Tissue Scaffolds ,business.industry ,General Medicine ,021001 nanoscience & nanotechnology ,020601 biomedical engineering ,Flow velocity ,Cell seeding ,Fiber geometry ,Printing, Three-Dimensional ,Seeding ,0210 nano-technology ,business ,Porosity ,Biotechnology ,Biomedical engineering - Abstract
Cell seeding on 3D scaffolds is a very delicate step in tissue engineering applications, influencing the outcome of the subsequent culture phase, and determining the results of the entire experiment. Thus, it is crucial to maximize its efficiency. To this purpose, a detailed study of the influence of the geometry of the scaffold fibers on dynamic seeding efficiency is presented. 3D printing technology was used to realize polylactic acid porous scaffolds, formed by fibers with a non-circular cross-sectional geometry, named multilobed to highlight the presence of niches and ridges. An oscillating perfusion bioreactor was used to perform bidirectional dynamic seeding of MG63 cells. The fiber shape influences the fluid dynamic parameters of the flow, affecting values of fluid velocity and wall shear stress. The path followed by cells through the scaffold fibers is also affected and results in a larger number of adhered cells in multilobed scaffolds compared to scaffolds with standard pseudo cylindrical fibers. Geometrical and fluid dynamic features can also have an influence on the morphology of adhered cells. The obtained results suggest that the reciprocal influence of geometrical and fluid dynamic features and their combined effect on cell trajectories should be considered to improve the dynamic seeding efficiency when designing scaffold architecture.
- Published
- 2021
17. Radiobiological studies of microvascular damage through in vitro models: A methodological perspective
- Author
-
Simone Bersini, Chiara Arrigoni, Tiziana Rancati, Veronica Sangalli, Maria Laura Costantino, Andrea Rossoni, Matteo Moretti, Laura Mecchi, Christian Candrian, Alessandro Cicchetti, and Luca Possenti
- Subjects
Ionizing radiation ,Cancer Research ,Microenvironment ,medicine.medical_treatment ,Cell ,Normal tissue ,Healthy tissue ,Review ,in-vitro model ,lcsh:RC254-282 ,In vitro model ,03 medical and health sciences ,0302 clinical medicine ,Microvasculature ,Organ‐on‐chip ,Medicine ,Clinical scenario ,030304 developmental biology ,0303 health sciences ,Radiotherapy ,business.industry ,Limiting ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,In vitro ,3. Good health ,Radiation therapy ,Radiobiological models ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Cancer research ,organ-on-chip ,business ,In‐vitro model - Abstract
Simple Summary Ionizing radiation is used as a treatment for cancer, but it also affects the endothelial cells that make up the microvasculature. In-vitro models can be used to study the detrimental effect of irradiation on those cells. This systematic review analyzed the literature models, highlighting the critical components of the production, irradiation, and analysis of radiobiological in-vitro models for microvascular endothelial cell damage. Based on those data, we suggest future directions, including advanced in-vitro models to recapitulate microenvironment features. We pinpoint essential information to be included for the good characterization of the experiments, especially in terms of the dose delivered by ionizing radiation. Abstract Ionizing radiation (IR) is used in radiotherapy as a treatment to destroy cancer. Such treatment also affects other tissues, resulting in the so-called normal tissue complications. Endothelial cells (ECs) composing the microvasculature have essential roles in the microenvironment’s homeostasis (ME). Thus, detrimental effects induced by irradiation on ECs can influence both the tumor and healthy tissue. In-vitro models can be advantageous to study these phenomena. In this systematic review, we analyzed in-vitro models of ECs subjected to IR. We highlighted the critical issues involved in the production, irradiation, and analysis of such radiobiological in-vitro models to study microvascular endothelial cells damage. For each step, we analyzed common methodologies and critical points required to obtain a reliable model. We identified the generation of a 3D environment for model production and the inclusion of heterogeneous cell populations for a reliable ME recapitulation. Additionally, we highlighted how essential information on the irradiation scheme, crucial to correlate better observed in vitro effects to the clinical scenario, are often neglected in the analyzed studies, limiting the translation of achieved results.
- Published
- 2021
18. Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
- Author
-
Anton G. Henssen, Laura Romero-Pérez, Chiara Arrigoni, Shunya Ohmura, Giuseppina Sannino, Marlene Dallmayer, David Saucier, Martin F. Orth, Florencia Cidre-Aranaz, Thomas G. P. Grunewald, Maximilian M. L. Knott, James F. Amatruda, Tilman L B Hölting, Julian Musa, Fabienne S. Wehweck, Stefanie Stein, Thomas Kirchner, Michaela C. Baldauf, Maria Vittoria Colombo, Aruna Marchetto, Victor Bardinet, Julia S. Gerke, Jing Li, Andrea Cossarizza, and Matteo Moretti
- Subjects
Adult ,Oncogene Proteins, Fusion ,Science ,Vulnerability ,General Physics and Astronomy ,Bone Neoplasms ,Sarcoma, Ewing ,Biology ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,Paediatric cancer ,Mice ,Targeted therapies ,Chondrocytes ,Cell Line, Tumor ,Bone cancer ,medicine ,Animals ,Humans ,Child ,Transcription factor ,Cell Proliferation ,Oligonucleotide Array Sequence Analysis ,Multidisciplinary ,Gene Expression Profiling ,Sarcoma ,Mesenchymal Stem Cells ,Oncogenes ,General Chemistry ,DNA Methylation ,medicine.disease ,Publisher Correction ,Mitochondria ,Gene Expression Regulation, Neoplastic ,Oxidative Stress ,Enhancer Elements, Genetic ,HEK293 Cells ,Hydrazines ,Cancer research ,RNA Interference ,SOXD Transcription Factors ,Oxidative stress ,Microsatellite Repeats - Abstract
Ewing sarcoma (EwS) is an aggressive childhood cancer likely originating from mesenchymal stem cells or osteo-chondrogenic progenitors. It is characterized by fusion oncoproteins involving EWSR1 and variable members of the ETS-family of transcription factors (in 85% FLI1). EWSR1-FLI1 can induce target genes by using GGAA-microsatellites as enhancers.Here, we show that EWSR1-FLI1 hijacks the developmental transcription factor SOX6 - a physiological driver of proliferation of osteo-chondrogenic progenitors - by binding to an intronic GGAA-microsatellite, which promotes EwS growth in vitro and in vivo. Through integration of transcriptome-profiling, published drug-screening data, and functional in vitro and in vivo experiments including 3D and PDX models, we discover that constitutively high SOX6 expression promotes elevated levels of oxidative stress that create a therapeutic vulnerability toward the oxidative stress-inducing drug Elesclomol.Collectively, our results exemplify how aberrant activation of a developmental transcription factor by a dominant oncogene can promote malignancy, but provide opportunities for targeted therapy.
- Published
- 2020
- Full Text
- View/download PDF
19. Engineering the early bone metastatic niche through human vascularized immuno bone minitissues
- Author
-
Enrico Ragni, Gabriele Candiani, Veronica Sansoni, Giovanni Lombardi, Maria Vittoria Colombo, Simone Bersini, Chiara Arrigoni, Matteo Moretti, and Mara Gilardi
- Subjects
bone–tumor interactions ,0206 medical engineering ,Biomedical Engineering ,Macrophage polarization ,Bioengineering ,Bone Neoplasms ,02 engineering and technology ,Biochemistry ,Bone and Bones ,Metastasis ,Biomaterials ,breast cancer ,Breast cancer ,bone metastases ,Metastatic niche ,Cell Line, Tumor ,3D in vitro models ,medicine ,Tumor Microenvironment ,Animals ,Humans ,Doxorubicin ,Tissue Engineering ,business.industry ,Cancer ,Endothelial Cells ,General Medicine ,021001 nanoscience & nanotechnology ,medicine.disease ,020601 biomedical engineering ,In vitro ,3. Good health ,drug efficacy ,Cancer research ,Animal studies ,0210 nano-technology ,business ,Biotechnology ,medicine.drug - Abstract
Bone metastases occur in 65%–80% advanced breast cancer patients. Although significant progresses have been made in understanding the biological mechanisms driving the bone metastatic cascade, traditional 2D in vitro models and animal studies are not effectively reproducing breast cancer cells (CCs) interactions with the bone microenvironment and suffer from species-specific differences, respectively. Moreover, simplified in vitro models cannot realistically estimate drug anti-tumoral properties and side effects, hence leading to pre-clinical testing frequent failures. To solve this issue, a 3D metastatic bone minitissue (MBm) is designed with embedded human osteoblasts, osteoclasts, bone-resident macrophages, endothelial cells and breast CCs. This minitissue recapitulates key features of the bone metastatic niche, including the alteration of macrophage polarization and microvascular architecture, along with the induction of CC micrometastases and osteomimicry. The minitissue reflects breast CC organ-specific metastatization to bone compared to a muscle minitissue. Finally, two FDA approved drugs, doxorubicin and rapamycin, have been tested showing that the dose required to impair CC growth is significantly higher in the MBm compared to a simpler CC monoculture minitissue. The MBm allows the investigation of metastasis key biological features and represents a reliable tool to better predict drug effects on the metastatic bone microenvironment.
- Published
- 2020
20. Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
- Author
-
Florencia Cidre-Aranaz, Thomas G. P. Grunewald, Chiara Arrigoni, Maximilian M. L. Knott, David Saucier, Shunya Ohmura, Fabienne S. Wehweck, Stefanie Stein, Maria Vittoria Colombo, Giuseppina Sannino, Marlene Dallmayer, Tilman L. B. Hoelting, Jing Li, Matteo Moretti, Julian Musa, Julia S. Gerke, Victor Bardinet, Laura Romero-Pérez, James F. Amatruda, Michaela C. Baldauf, Thomas Kirchner, Andrea Cossarizza, Aruna Marchetto, Martin F. Orth, and Anton G. Henssen
- Subjects
0301 basic medicine ,Cancer Research ,Science ,medicine.medical_treatment ,General Physics and Astronomy ,Biology ,Article ,General Biochemistry, Genetics and Molecular Biology ,Targeted therapy ,Paediatric cancer ,03 medical and health sciences ,Targeted therapies ,0302 clinical medicine ,RNA interference ,Bone cancer ,medicine ,lcsh:Science ,Transcription factor ,Regulation of gene expression ,Multidisciplinary ,Oncogene ,fungi ,Sarcoma ,Oncogenes ,General Chemistry ,3. Good health ,Gene expression profiling ,030104 developmental biology ,030220 oncology & carcinogenesis ,FLI1 ,DNA methylation ,Cancer research ,lcsh:Q - Abstract
Ewing sarcoma (EwS) is an aggressive childhood cancer likely originating from mesenchymal stem cells or osteo-chondrogenic progenitors. It is characterized by fusion oncoproteins involving EWSR1 and variable members of the ETS-family of transcription factors (in 85% FLI1). EWSR1-FLI1 can induce target genes by using GGAA-microsatellites as enhancers. Here, we show that EWSR1-FLI1 hijacks the developmental transcription factor SOX6 – a physiological driver of proliferation of osteo-chondrogenic progenitors – by binding to an intronic GGAA-microsatellite, which promotes EwS growth in vitro and in vivo. Through integration of transcriptome-profiling, published drug-screening data, and functional in vitro and in vivo experiments including 3D and PDX models, we discover that constitutively high SOX6 expression promotes elevated levels of oxidative stress that create a therapeutic vulnerability toward the oxidative stress-inducing drug Elesclomol. Collectively, our results exemplify how aberrant activation of a developmental transcription factor by a dominant oncogene can promote malignancy, but provide opportunities for targeted therapy., Ewing sarcoma is characterized by the fusion of EWSR1 and FLI1. Here, the authors show that EWSR1-FLI1 increases the activity of the developmental transcription factor SOX6, which promotes tumor growth but also increases sensitivity to oxidative stress.
- Published
- 2020
- Full Text
- View/download PDF
21. Le fratture della mano in età pediatrica
- Author
-
Chiara Arrigoni and Filippo M. Sénès
- Subjects
body regions ,medicine.medical_specialty ,business.industry ,Orthopedic surgery ,Skin loss ,medicine ,Phalanx ,business ,Carpal fractures ,Surgery - Abstract
Phalangeal fractures are the most common hand fractures in children and the distal phalanx is the most injured. Minor fingertip injuries are very common; sometimes simple wound care might be enough but, in cases of larger skin loss, local or regional flaps could be required. Carpal fractures are rare, almost always observed in adolescents rather than in children, whereas metacarpal fractures are most commonly metaphyseal compression fractures or Salter–Harris type II physeal fractures.
- Published
- 2018
- Full Text
- View/download PDF
22. Oncogenic hijacking of a developmental transcription factor evokes therapeutic vulnerability for ROS-induction in Ewing sarcoma
- Author
-
Shunya Ohmura, Florencia Cidre-Aranaz, Thomas Kirchner, Laura Romero-Pérez, Tilman L. B. Hoelting, Thomas G. P. Grunewald, Stefanie Stein, David Saucier, Maximilian M. L. Knott, Jing Li, James F. Amatruda, Michaela C. Baldauf, Aruna Marchetto, Julia S. Gerke, Matteo Moretti, Chiara Arrigoni, Giuseppina Sannino, Marlene Dallmayer, Julian Musa, Fabienne S. Wehweck, and Martin F. Orth
- Subjects
Oncogene ,medicine.medical_treatment ,Mesenchymal stem cell ,fungi ,Biology ,Targeted therapy ,chemistry.chemical_compound ,chemistry ,FLI1 ,medicine ,Cancer research ,Elesclomol ,Progenitor cell ,Enhancer ,Transcription factor - Abstract
Ewing sarcoma (EwS) is an aggressive childhood cancer likely originating from mesenchymal stem cells or osteo-chondrogenic progenitors. It is characterized by fusion oncoproteins involving EWSR1 and variable members of the ETS-family of transcription factors (in 85% FLI1). EWSR1-FLI1 can induce target genes by using GGAA-microsatellites (mSats) as enhancers.Here, we show that EWSR1-FLI1 hijacks the developmental transcription factor SOX6 – a physiological driver of proliferation of osteo-chondrogenic progenitors – by binding to an intronic GGAA-mSat, which promotes EwS growthin vitroandin vivo. Through integration of transcriptome-profiling, published drug-screening data, and functionalin vitroandin vivoexperiments, we discovered that SOX6 interferes with the antioxidant system resulting in constitutively elevated reactive oxygen species (ROS) levels that create a therapeutic vulnerability toward the ROS-inducing drug Elesclomol.Collectively, our results exemplify how aberrant activation of a developmental transcription factor by a dominant oncogene can promote malignancy, but provide opportunities for targeted therapy.
- Published
- 2019
- Full Text
- View/download PDF
23. Correction: A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β3 impact breast cancer cell extravasation
- Author
-
Martina Crippa, Simone Bersini, Mara Gilardi, Chiara Arrigoni, Sara Gamba, Anna Falanga, Christian Candrian, Gabriele Dubini, Marco Vanoni, and Matteo Moretti
- Subjects
Biomedical Engineering ,Bioengineering ,General Chemistry ,Biochemistry - Abstract
Correction for ‘A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β3 impact breast cancer cell extravasation’ by Martina Crippa et al., Lab Chip, 2021, DOI: 10.1039/d0lc01011a.
- Published
- 2021
- Full Text
- View/download PDF
24. Engineered miniaturized models of musculoskeletal diseases
- Author
-
Matilde Bongio, Ivan Martin, Silvia Lopa, Simone Bersini, Chiara Arrigoni, and Matteo Moretti
- Subjects
0301 basic medicine ,Pharmacology ,Computer science ,Nanotechnology ,Models, Biological ,Structure and function ,Tissue Culture Techniques ,03 medical and health sciences ,030104 developmental biology ,Muscular Diseases ,Drug Discovery ,Animals ,Humans ,Bone Diseases ,Neuroscience - Abstract
The musculoskeletal system is an incredible machine that protects, supports and moves the human body. However, several diseases can limit its functionality, compromising patient quality of life. Designing novel pathological models would help to clarify the mechanisms driving such diseases, identify new biomarkers and screen potential drug candidates. Miniaturized models in particular can mimic the structure and function of basic tissue units within highly controlled microenvironments, overcoming the limitations of traditional macroscale models and complementing animal studies, which despite being closer to the in vivo situation, are affected by species-specific differences. Here, we discuss the miniaturized models engineered over the past few years to analyze osteochondral and skeletal muscle pathologies, demonstrating how the rationale design of novel systems could provide key insights into the pathological mechanisms behind diseases of the musculoskeletal system.
- Published
- 2016
- Full Text
- View/download PDF
25. Total knee arthroplasty and infection: how surgeons can reduce the risks
- Author
-
Matteo Bruzzone, Federica Rosso, Davide Edoardo Bonasia, Roberto Rossi, Chiara Arrigoni, Nicola Ratto, and Federico Dettoni
- Subjects
medicine.medical_specialty ,Blood transfusion ,Total Knee Arthroplasty ,medicine.medical_treatment ,Total knee arthroplasty ,infection ,risk factors ,surgeons ,total knee arthroplasty ,03 medical and health sciences ,Wound care ,0302 clinical medicine ,Risk Factors ,medicine ,Orthopedics and Sports Medicine ,Knee ,030212 general & internal medicine ,Significant risk ,Antibiotic prophylaxis ,Surgeons ,030222 orthopedics ,business.industry ,Risk of infection ,Chlorhexidine ,Surgery ,Increased risk ,business ,Infection ,medicine.drug - Abstract
Total joint arthroplasty (TJA) is one of the most common orthopaedic procedures. Nevertheless, several complications can lead to implant failure. Peri-prosthetic joint infections (PJI) certainly represent a significant challenge in TJA, constituting a major cause of prosthetic revision. The surgeon may have an important role in reducing the PJI rate by limiting the impact of significant risk factors associated to either the patient, the operative environment or the post-operative care. In the pre-operative period, several preventive measures may be adopted to manage reversible medical comorbidities. Other recognised pre-operative risk factors are urinary tract infections, intra-articular corticosteroid injections and nasal colonisation with Staphylococcus (S.) aureus, particularly the methicillin-resistant strain (MRSA). In the intra-operative setting, protective measures for PJI include antibiotic prophylaxis, surgical-site antisepsis and use of pre-admission chlorhexidine washing and pulsed lavage during surgery. In this setting, the use of plastic adhesive drapes and sterile stockinette, as well as using personal protection systems, do not clearly reduce the risk of infection. On the contrary, using sterile theatre light handles and splash basins as well as an increased traffic in the operating room are all associated with an increased risk for PJI. In the post-operative period, other infections causing transient bacteraemia, blood transfusion and poor wound care are considered as risk factors for PJI. Cite this article: Ratto N, Arrigoni C, Rosso F, Bruzzone M, Dettoni F, Bonasia DE, Rossi R. Total knee arthroplasty and infection: how surgeons can reduce the risks. EFORT Open Rev 2016;1: 339-344 DOI: 10.1302/2058-5241.1.000032.
- Published
- 2016
26. Creep-resistant dextran-based polyurethane foam as a candidate scaffold for bone tissue engineering: Synthesis, chemico-physical characterization, and in vitro and in vivo biocompatibility
- Author
-
Cristina Lenardi, Alessandro Tocchio, Matteo Moretti, Federico Martello, Irini Gerges, Camilla Recordati, M. Tamplenizza, Silvia Lopa, Leonardo Ricotti, Paolo Milani, and Chiara Arrigoni
- Subjects
Scaffold ,Materials science ,Polymers and Plastics ,General Chemical Engineering ,0206 medical engineering ,regenerative medicine ,02 engineering and technology ,Regenerative medicine ,Analytical Chemistry ,chemistry.chemical_compound ,Tissue engineering ,Chemical Engineering (all) ,Thermal stability ,Composite material ,Polyurethane ,Mesenchymal stem cell ,Bone graft substitute ,composite scaffolds ,dextran ,polyurethane ,tissue engineering ,021001 nanoscience & nanotechnology ,020601 biomedical engineering ,In vitro ,Dextran ,chemistry ,0210 nano-technology ,Biomedical engineering - Abstract
A highly crosslinked composite dextran-based scaffold (named DexFoam) was tailored to overcome specific deficiencies of polymeric and ceramic bone scaffolds and to guarantee a bone-mimicking microenvironment for the proliferation of human mesenchymal stem cells in vitro. The creep resistance for up to 90% compressive stain, the capability to regain the original shape after deformation, and the good thermal stability in both physiological and “body limit” conditions make DexFoam a valid alternative to the currently available bone scaffolds. Histopathological evaluation for host reaction and tissue colonization of DexFoam scaffold, implanted subcutaneously in mice, demonstrated its in vivo biocompatibility and biodegradability.
- Published
- 2016
- Full Text
- View/download PDF
27. Sound-induced morphogenesis of multicellular systems for rapid orchestration of vascular networks
- Author
-
Elena Della Bella, Valentina Basoli, Dalila Petta, Christian Candrian, David Eglin, Matteo Moretti, Tiziano Serra, Mauro Alini, Jan Barcik, Angela R. Armiento, Riccardo Tognato, Chiara Arrigoni, Daniele Pellicciotta, and R. Geoff Richards
- Subjects
Materials science ,0206 medical engineering ,Microfluidics ,Biomedical Engineering ,Morphogenesis ,Bioengineering ,02 engineering and technology ,Biochemistry ,Regenerative medicine ,Biomaterials ,Vasculogenesis ,Process (anatomy) ,Mesenchymal stem cell ,Endothelial Cells ,Hydrogels ,General Medicine ,021001 nanoscience & nanotechnology ,020601 biomedical engineering ,Organoids ,Multicellular organism ,Sound ,Biophysics ,0210 nano-technology ,Developmental biology ,Biotechnology - Abstract
Morphogenesis, a complex process, ubiquitous in developmental biology and many pathologies, is based on self-patterning of cells. Spatial patterns of cells, organoids, or inorganic particles can be forced on demand using acoustic surface standing waves, such as the Faraday waves. This technology allows tuning of parameters (sound frequency, amplitude, chamber shape) under contactless, fast and mild culture conditions, for morphologically relevant tissue generation. We call this method Sound Induced Morphogenesis (SIM). In this work, we use SIM to achieve tight control over patterning of endothelial cells and mesenchymal stem cells densities within a hydrogel, with the endpoint formation of vascular structures. Here, we first parameterize our system to produce enhanced cell density gradients. Second, we allow for vasculogenesis after SIM patterning control and compare our controlled technology against state-of-the-art microfluidic culture systems, the latter characteristic of pure self-organized patterning and uniform initial density. Our sound-induced cell density patterning and subsequent vasculogenesis requires less cells than the microfluidic chamber. We advocate for the use of SIM for rapid, mild, and reproducible morphogenesis induction and further explorations in the regenerative medicine and cell therapy fields.
- Published
- 2020
- Full Text
- View/download PDF
28. Anatomic shoulder arthroplasty: an update on indications, technique, results and complication rates
- Author
-
Chiara Arrigoni, Filippo Castoldi, Lorenzo Mattei, and Stefano Mortera
- Subjects
medicine.medical_specialty ,complications ,medicine.medical_treatment ,indications ,modularity ,results ,shoulder arthroplasty ,shoulder fractures ,Arthropathy ,medicine ,Orthopedics and Sports Medicine ,Modularity (networks) ,business.industry ,Shoulder Fracture ,Persistent pain ,Rehabilitation ,Articles ,medicine.disease ,Arthroplasty ,Surgery ,Complication ,Range of motion ,business ,Shoulder replacement - Abstract
A shoulder replacement is indicated in patients affected by glenohumeral arthropathy with severely reduced range of motion, persistent pain, especially at night, and loss of strength. There is much discussion in the scientific community about the prosthetic options for these cases: hemiarthroplasty, anatomic total shoulder arthroplasty, and reverse total shoulder arthroplasty. We analyzed the indications for, results of, and complications associated with this kind of surgery, focusing on anatomic arthroplasty and on the concept of modularity.
- Published
- 2015
- Full Text
- View/download PDF
29. Tackling muscle fibrosis: From molecular mechanisms to next generation engineered models to predict drug delivery
- Author
-
Simona Zanotti, Mara Gilardi, Marina Mora, Christian Candrian, S. Krol, Matteo Moretti, Simone Bersini, and Chiara Arrigoni
- Subjects
0301 basic medicine ,business.industry ,Proteolytic enzymes ,Pharmaceutical Science ,Context (language use) ,Bioinformatics ,medicine.disease ,Fibrosis ,Models, Biological ,Skeletal muscle fibrosis ,Muscular Dystrophy, Duchenne ,03 medical and health sciences ,Therapeutic approach ,030104 developmental biology ,Drug Delivery Systems ,In vivo ,Drug delivery ,medicine ,Animals ,Humans ,Muscular dystrophy ,business ,Muscle, Skeletal ,Cell Engineering - Abstract
Muscle fibrosis represents the end stage consequence of different diseases, among which muscular dystrophies, leading to severe impairment of muscle functions. Muscle fibrosis involves the production of several growth factors, cytokines and proteolytic enzymes and is strictly associated to inflammatory processes. Moreover, fibrosis causes profound changes in tissue properties, including increased stiffness and density, lower pH and oxygenation. Up to now, there is no therapeutic approach able to counteract the fibrotic process and treatments directed against muscle pathologies are severely impaired by the harsh conditions of the fibrotic environment. The design of new therapeutics thus need innovative tools mimicking the obstacles posed by the fibrotic environment to their delivery. This review will critically discuss the role of in vivo and 3D in vitro models in this context and the characteristics that an ideal model should possess to help the translation from bench to bedside of new candidate anti-fibrotic agents.
- Published
- 2017
30. Catch-and-Release of Target Cells Using Aptamer-Conjugated Electroactive Zwitterionic Oligopeptide SAM
- Author
-
Elena Bianchi, Gabriele Dubini, Tatsuto Kageyama, Matteo Moretti, Chiara Arrigoni, Alfonso Gautieri, Flavia Bonalumi, Junko Enomoto, Tatsuya Osaki, Francesca Marchese, and Junji Fukuda
- Subjects
0301 basic medicine ,Oligopeptide ,Multidisciplinary ,Chemistry ,Aptamer ,Cell Separation ,Electrochemical Techniques ,Aptamers, Nucleotide ,Conjugated system ,Article ,03 medical and health sciences ,030104 developmental biology ,Molecular recognition ,Tissue engineering ,Cell culture ,Cell Line, Tumor ,Cancer cell ,Nucleic acid ,Biophysics ,Humans ,Oligopeptides - Abstract
Nucleic acid aptamers possess attractive features such as specific molecular recognition, high-affinity binding, and rapid acquisition and replication, which could be feasible components for separating specific cells from other cell types. This study demonstrates that aptamers conjugated to an oligopeptide self-assembled monolayer (SAM) can be used to selectively trap human hepatic cancer cells from cell mixtures containing normal human hepatocytes or human fibroblasts. Molecular dynamics calculations have been performed to understand how the configurations of the aptamers are related to the experimental results of selective cell capture. We further demonstrate that the captured hepatic cancer cells can be detached and collected along with electrochemical desorption of the oligopeptide SAM, and by repeating these catch-and-release processes, target cells can be enriched. This combination of capture with aptamers and detachment with electrochemical reactions is a promising tool in various research fields ranging from basic cancer research to tissue engineering applications.
- Published
- 2017
- Full Text
- View/download PDF
31. A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone
- Author
-
Simone Bersini, Chiara Arrigoni, Seok Chung, Roger D. Kamm, Matteo Moretti, Joseph L. Charest, Gabriele Dubini, Jessie S. Jeon, Charles Stark Draper Laboratory, Massachusetts Institute of Technology. Department of Biological Engineering, Massachusetts Institute of Technology. Department of Mechanical Engineering, Jeon, Jessie S, Charest, Joseph, and Kamm, Roger Dale
- Subjects
Chemokine CXCL5 ,Pathology ,medicine.medical_specialty ,Microfluidics ,Biophysics ,Fluorescent Antibody Technique ,Bone Marrow Cells ,Bone Neoplasms ,Breast Neoplasms ,Bioengineering ,Article ,Receptors, Interleukin-8B ,Metastasis ,Biomaterials ,Circulating tumor cell ,Breast cancer ,Cancer stem cell ,Cell Line, Tumor ,Humans ,Medicine ,Cell Proliferation ,business.industry ,Cancer ,Cell Differentiation ,Mesenchymal Stem Cells ,medicine.disease ,Metastatic breast cancer ,Extravasation ,Mechanics of Materials ,Cancer cell ,Ceramics and Composites ,Female ,Collagen ,business - Abstract
Cancer metastases arise following extravasation of circulating tumor cells with certain tumors exhibiting high organ specificity. Here, we developed a 3D microfluidic model to analyze the specificity of human breast cancer metastases to bone, recreating a vascularized osteo-cell conditioned microenvironment with human osteo-differentiated bone marrow-derived mesenchymal stem cells and endothelial cells. The tri-culture system allowed us to study the transendothelial migration of highly metastatic breast cancer cells and to monitor their behavior within the bone-like matrix. Extravasation, quantified 24 h after cancer cell injection, was significantly higher in the osteo-cell conditioned microenvironment compared to collagen gel-only matrices (77.5 ± 3.7% vs. 37.6 ± 7.3%), and the migration distance was also significantly greater (50.8 ± 6.2 μm vs. 31.8 ± 5.0 μm). Extravasated cells proliferated to form micrometastases of various sizes containing 4 to more than 60 cells by day 5. We demonstrated that the breast cancer cell receptor CXCR2 and the bone-secreted chemokine CXCL5 play a major role in the extravasation process, influencing extravasation rate and traveled distance. Our study provides novel 3D in vitro quantitative data on extravasation and micrometastasis generation of breast cancer cells within a bone-like microenvironment and demonstrates the potential value of microfluidic systems to better understand cancer biology and screen for new therapeutics., National Cancer Institute (U.S.) (R33 CA174550-01), National Cancer Institute (U.S.) (R21 CA140096), Italian Ministry of Health (Fellowship), Fondazione Fratelli Agostino and Enrico Rocca (Progetto Rocca Doctoral Fellowship), Repligen Corporation (Fellowship in Cancer Research), Charles Stark Draper Laboratory (Fellowship), National Research Foundation of Korea (NRF (2012-022481), Korean Energy Technology Evaluation and Planning (KETEP) (20124010203250)
- Published
- 2014
- Full Text
- View/download PDF
32. Adult Hip Flexion Contracture due to Neurological Disease: A New Treatment Protocol—Surgical Treatment of Neurological Hip Flexion Contracture
- Author
-
Andrea Bersano, Alberto Nicodemo, Alessandro Massè, and Chiara Arrigoni
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Groin ,business.industry ,lcsh:R ,Hyperlordosis ,lcsh:Medicine ,Case Report ,General Medicine ,Scoliosis ,medicine.disease ,Cerebral palsy ,Physical medicine and rehabilitation ,medicine.anatomical_structure ,Lumbar ,medicine ,Physical therapy ,Contracture ,medicine.symptom ,business ,Range of motion ,Paraplegia - Abstract
Congenital, traumatic, or extrinsic causes can lead people to paraplegia; some of these are potentially; reversible and others are not. Paraplegia can couse hip flexion contracture and, consequently, pressure sores, scoliosis, and hyperlordosis; lumbar and groin pain are strictly correlated. Scientific literature contains many studies about children hip flexion related to neurological diseases, mainly caused by cerebral palsy; only few papers focus on this complication in adults. In this study we report our experience on surgical treatment of adult hip flexion contracture due to neurological diseases; we have tried to outline an algorithm to choose the best treatment avoiding useless or too aggressive therapies. We present 5 cases of adult hips flexion due to neurological conditions treated following our algorithm. At 1-year-follow-up all patients had a good clinical outcome in terms of hip range of motion, pain and recovery of walking if possible. In conclusion we think that this algorithm could be a good guideline to treat these complex cases even if we need to treat more patients to confirm this theory. We believe also that postoperation physiotherapy it is useful in hip motility preservation, improvement of muscular function, and walking ability recovery when possible.
- Published
- 2014
- Full Text
- View/download PDF
33. Characterization of articular chondrocytes isolated from 211 osteoarthritic patients
- Author
-
Valerio Sansone, Matteo Moretti, Manuela Teresa Raimondi, Silvia Lopa, Chiara Arrigoni, Matteo Laganà, and Luigi Zagra
- Subjects
Adult ,Cartilage, Articular ,Male ,Aging ,medicine.medical_specialty ,Knee Joint ,Arthroplasty, Replacement, Hip ,medicine.medical_treatment ,Biomedical Engineering ,Osteoarthritis ,Biomaterials ,Andrology ,Chondrocytes ,Proliferation rate ,medicine ,Humans ,Total joint replacement ,Arthroplasty, Replacement, Knee ,Cartilage degeneration ,Aged ,Cell Proliferation ,Aged, 80 and over ,Transplantation ,business.industry ,Cartilage ,Mean age ,Cell Biology ,Middle Aged ,medicine.disease ,Arthroplasty ,Surgery ,medicine.anatomical_structure ,Female ,Hip Joint ,business - Abstract
We analyzed specific features of chondrocytes as cellular yield, cell doubling rates and the dependence between these parameters and patient-related data in a set of 211 osteoarthritic (OA) patients undergoing total joint replacement. For each patient the data available were joint type, age and gender. Knee samples chosen randomly among all biopsies were graded according to ICRS score. Patients' age ranged between 30 and 90 years with a mean age of 66 ± 9.7 years. Patients were divided into age classes and statistically significant differences in proliferation rate at passage 1 were found between chondrocytes derived from young and old donors, with the last ones characterized by a lower proliferation rate. A similar trend was observed for proliferation rate at passage 2. For all the samples, cellular yields ranged between 0.1 and 5.5 million cells/g of tissue. No significant correlation was observed between the level of cartilage degeneration (ICRS score) and cellular yield and proliferation rates. However, in samples with a high degree of cartilage degeneration (ICRS score 4) the cellular yield was lower compared to the other three groups (ICRS scores 1-3). In this study we performed a systematic characterization of basic parameters of chondrocytes originating from a wide group of OA patients. Considering the use of autologous chondrocytes in chondral treatments, the characterization of cell basic features may represent an important step to determine the quality of the cell source which is a major determinant in the outcome of cell-based therapies.
- Published
- 2013
- Full Text
- View/download PDF
34. In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone
- Author
-
Simone Bersini, Chiara Arrigoni, Mara Gilardi, Matteo Moretti, Arrigoni, C, Bersini, S, Gilardi, M, and Moretti, M
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Bone Neoplasms ,Breast Neoplasms ,Review ,Catalysis ,Catalysi ,Inorganic Chemistry ,lcsh:Chemistry ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,In vitro model ,In vivo ,Cell Line, Tumor ,Bone cell ,Medicine ,Animals ,Humans ,breast carcinoma ,Physical and Theoretical Chemistry ,Molecular Biology ,lcsh:QH301-705.5 ,Spectroscopy ,bone metastasis ,in vitro models ,business.industry ,Organic Chemistry ,Intravasation ,Computer Science Applications1707 Computer Vision and Pattern Recognition ,General Medicine ,medicine.disease ,Primary tumor ,co-culture ,In vitro ,Extravasation ,Coculture Techniques ,Computer Science Applications ,Crosstalk (biology) ,030104 developmental biology ,lcsh:Biology (General) ,lcsh:QD1-999 ,Bone metastasi ,030220 oncology & carcinogenesis ,Cancer research ,Disease Progression ,Female ,business - Abstract
Advanced breast cancer frequently metastasizes to bone through a multistep process involving the detachment of cells from the primary tumor, their intravasation into the bloodstream, adhesion to the endothelium and extravasation into the bone, culminating with the establishment of a vicious cycle causing extensive bone lysis. In recent years, the crosstalk between tumor cells and secondary organs microenvironment is gaining much attention, being indicated as a crucial aspect in all metastatic steps. To investigate the complex interrelation between the tumor and the microenvironment, both in vitro and in vivo models have been exploited. In vitro models have some advantages over in vivo, mainly the possibility to thoroughly dissect in controlled conditions and with only human cells the cellular and molecular mechanisms underlying the metastatic progression. In this article we will review the main results deriving from in vitro co-culture models, describing mechanisms activated in the crosstalk between breast cancer and bone cells which drive the different metastatic steps.
- Published
- 2016
35. The effect of polyurethane scaffold surface treatments on the adhesion of chondrocytes subjected to interstitial perfusion culture
- Author
-
Serena Bertoldi, Silvia Caddeo, Chiara Arrigoni, Manuela Teresa Raimondi, Silvia Farè, and Matteo Moretti
- Subjects
Polyurethane ,Plasma coating ,Chemistry ,Cell growth ,0206 medical engineering ,Bioreactor ,Biomedical Engineering ,Medicine (miscellaneous) ,02 engineering and technology ,Adhesion ,Matrix (biology) ,021001 nanoscience & nanotechnology ,020601 biomedical engineering ,Perfusion ,Scaffold ,Tissue engineering ,Perfusion Culture ,Original Article ,0210 nano-technology ,Cell adhesion ,Fetal bovine serum ,Biomedical engineering - Abstract
The purpose of this study was to measure chondrocytes detachment from cellularized constructs cultured in a perfusion bioreactor, and to evaluate the effect of different scaffold coatings on cell adhesion under a fixed flow rate. The scaffolds were polyurethane foams, treated to promote cell attachment and seeded with human chondrocytes. In a preliminary static culture experiment, the scaffolds were imbibed with fetal bovine serum (FBS) and then cultured for 4 weeks. To quantify cell detachment, the number of detached cells from the scaffold treated with FBS was estimated under different interstitial perfusion flow rates and shear stress levels (0.005 mL/min equivalent to 0.05 mPa, 0.023 mL/min equivalent to 0.23 mPa, and 0.045 mL/min equivalent to 0.45 mPa). Finally, groups of scaffolds differently treated (FBS, plasma plus FBS, plasma plus collagen type I) were cultured under a fixed perfusion rate of 0.009 mL/min, equivalent to a shear stress of 0.09 mPa, and the detached cells were counted. Static cultivation showed that cell proliferation increased with time and matrix biosynthesis decreased after the first week of culture. Perfused culture showed that the number of detached cells increased with the perfusion rate on FBS-treated constructs. The plasma-treated/collagen-coated scaffolds showed the highest resistance to cell detachment. To minimize cell detachment, the perfusion rate must be maintained in the order of 0.02 mL/min, giving a shear stress of 0.2 mPa. Our set-up allowed estimating the resistance to cell detachment under interstitial perfusion in a repeatable manner, to test other scaffold coatings and cell types.
- Published
- 2015
36. Vascular tissue engineering
- Author
-
Andrea Remuzzi, Davide Camozzi, and Chiara Arrigoni
- Subjects
0301 basic medicine ,Biomedical Engineering ,lcsh:Medicine ,vascular tissue engineering ,vascular cells ,Bioreactors ,scaffolds ,03 medical and health sciences ,0302 clinical medicine ,Cell transplantation ,Tissue engineering ,Blood vessel prosthesis ,Medicine ,Humans ,Bioartificial Organ ,Transplantation ,Bioartificial Organs ,Tissue Engineering ,business.industry ,lcsh:R ,Settore ING-IND/34 - Bioingegneria Industriale ,Cell Biology ,Blood Vessel Prosthesis ,030104 developmental biology ,Biodegradation, Environmental ,Biodegradable scaffold ,Vascular tissue engineering ,Blood supply ,business ,030217 neurology & neurosurgery ,Thrombotic complication ,Biomedical engineering - Abstract
Reconstructive surgery using autologous vessels is the conventional approach for substitution of diseased vessels or for generation of bypass to improve blood supply downstream of stenosed vessels. In some circumstances the use of autologous material is not possible due to concomitant diseases or previous use, and artificial grafts must be used. Unfortunately, these grafts cannot substitute small-caliber arterial vessels because of thrombotic complications. The objective of tissue engineering at the vascular level is then to generate biological substitutes of arterial conduits with functional characteristics of native vessels, combining cellular components with biodegradable scaffolds. These research projects started in several laboratories, in the late 1990s, and have expanded in different directions using a number of experimental approaches. The objective of this review is to give an overview of the results so far obtained in this area of research, and to discuss the problems related to these investigations, at the experimental and clinical level. The article provides an overview of different biodegradable scaffolds used, experimental techniques for vessels maturation in vitro under mechanical stimulation, and of differentiated as well as precursors of vascular cells, which opens new opportunities for further development of this form of cell transplantation. Finally, the current available results in clinical research will be discussed.
- Published
- 2006
37. Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases
- Author
-
Chiara Arrigoni, Mara Gilardi, Matteo Moretti, Massimo Broggini, Paola De Luca, Sara Previdi, Arrigoni, C, De Luca, P, Gilardi, M, Previdi, S, Broggini, M, and Moretti, M
- Subjects
musculoskeletal diseases ,Pathology ,medicine.medical_specialty ,Cancer Research ,Stromal cell ,Short Communication ,Cellular differentiation ,Bone Neoplasms ,Breast Neoplasms ,Cell Communication ,Bone Neoplasm ,Heterotypic cell contacts ,RANKL pathway ,Cell Movement ,Osteogenesis ,Gene expression analyses ,Bone cell ,medicine ,Humans ,Coculture Technique ,Cell Aggregation ,Cell Proliferation ,Mesenchymal Stromal Cell ,biology ,RANK Ligand ,Mesenchymal stem cell ,Osteoprotegerin ,Bone metastasis ,Mesenchymal Stem Cells ,Cell Differentiation ,medicine.disease ,Coculture Techniques ,Cell aggregation ,Cellular Microenvironment ,Gene Expression Regulation ,Oncology ,RANKL ,Cancer cell ,Cancer research ,biology.protein ,Molecular Medicine ,Female ,In vitro co-cultures ,Breast Neoplasm ,Human - Abstract
Background Bone metastases arise in nearly 70% of patients with advanced breast cancer, but the complex metastatic process has not been completely clarified yet. RANKL/RANK/OPG pathway modifications and the crosstalk between metastatic cells and bone have been indicated as potential drivers of the process. Interactions between tumor and bone cells have been studied in vivo and in vitro, but specific effects of the direct contact between human metastatic cells and human bone cells on RANKL/RANK/OPG pathway have not been investigated. Findings We directly co-cultured bone metastatic human breast cancer cells (BOKL) with osteo-differentiated human mesenchymal cells (BMSCs) from 3 different donors. BMSCs and BOKL were then enzymatically separated and FACS sorted. We found a significant increase in the RANKL/OPG ratio as compared to control, which was not observed in BOKL cultured in medium conditioned by BMSCs, neither in BOKL directly cultured with fibroblasts or medium conditioned by fibroblasts. Direct co-culture with osteo-differentiated BMSCs caused BOKL aggregation while proliferation was not affected by co-culture. To more specifically associate RANKL expression to osteogenic differentiation degree of BMSCs, we determined their osteogenic markers expression and matrix calcification relative to osteoblasts and fibroblasts. Conclusions In conclusion, our co-culture model allowed to demonstrate for the first time that direct contact but not paracrine interactions between human metastatic breast cancer cells and bone cells has a significant effect on RANKL/OPG expression in bone metastatic cells. Furthermore, only direct contact with the bone microenvironment induced BOKL clustering without however significantly influencing their proliferation and migration. Electronic supplementary material The online version of this article (doi:10.1186/1476-4598-13-238) contains supplementary material, which is available to authorized users.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.